Ledger.Open graph →

SEC Form D · filed July 27, 2020

Tallac Therapeutics, Inc

Offering

$40.4M

Sold

$21.2M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

BURLINGAME, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Hong Wan · Burlingame, CAExec · Director Isaac Cheng · Burlingame, CADirector Corey Goodman · Burlingame, CADirector Michael Carusi · Burlingame, CADirector Jaume Pons · Burlingame, CADirector Christine Brennan · Burlingame, CADirector Weston Reynolds · New York, NYDirector Andrew Menlove · SALT LAKE CITY, UTDirector Greg Moritz · Marietta, GADirector Connor Mclaughlin · NEW YORK, NYDirector Tally Ringwood · SALT LAKE CITY, UTDirector Shreyans Jain · Frisco, TXExec · Director Josh Sharkey · Cortlandt Manor, NYDirector Jonathan Davila · Tampa, FLExec · Director Mark Swanson · Tampa, FLDirector Matthew Leyrer · Dallas, TXDirector Scott Mcmullin · Los Angeles, CADirector Christopher Rising · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗